Experiment 635087
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | MAS,R: RIVAS,P: IZQUIERDO,JE: HERNANDEZ,R: FERNANDEZ,L: FERNANDEZ,J: ORTA,SD: ILLNAIT,J: RICARDO,Y:. (1999). PHARMACOEPIDEMIOLOGIC STUDY OF POLICOSANOL.. 60(8) |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHARMACOEPIDEMILOGIC, OPEN-LABEL COHORT STUDY INCLUDING 6611 PATIENTS. AND INCLUDED A POLICOSANOL-TREATED GROUP AND A CONTROL GROUP POLICOSANOL WAS ADMINSTERED AT THE STARTING DOSE OF 5 MG/D (97.6%) 10 MG/D (1.9%) AND 15 MG/D IN (0.4%) DURATION OF THERAPY RANGED FROM 2 MONTH TO 5 YEARS. RESULTS OF THE STUDY SHOWED GOOD TOLEREABILITY TO POLICOSONAL AND SUPPORTS ITS RISK-TO-BENEFIT RATIO IN THE STUDY POPULATION. |
| Dose amount | VAR MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |